Dr. Camidge is a thoracic oncologist at the University of Colorado. He has been the Director of CU’s Thoracic Oncology Clinical Program and Clinical Research Program since 2007. His approach to treating pleural mesothelioma and lung cancer focuses on a personalized approach in which treatment plans are based on the results of specific tests to
Because asbestos has been used all over the world, malignant pleural mesothelioma has become a global problem. The search for effective treatments is being conducted all over the world, and researchers from the Hyogo College of Medicine recently shared positive results from a study of an inhalable gene therapy.
Robotic surgery represents one of the most innovative breakthroughs for treating patients with malignant pleural mesothelioma. Its development has provided new options for patients whose tumors were so inaccessible that they would previously have been referred for palliative care. In the skilled hands of some of the world’s most accomplished thoracic surgeons, minimally invasive robotic
Dr. Anthony W. Kim is an internationally respected thoracic surgeon and oncologist. He leads the thoracic surgery division and program at Keck Medicine of the University of Southern California. He treats patients with thoracic cancers, including pleural mesothelioma and lung cancer, and specializes in minimally invasive surgery, including both thoracoscopic and robotic surgery. Education and
Dr. Scott M. Atay is a thoracic surgeon at Keck Medicine of USC in southern California. He specializes in treating malignant diseases, including pleural mesothelioma, lung cancer, and esophageal cancer. He is an Assistant Professor of Clinical Surgery and the Surgical Director of the USC Lung Transplant Program. Education and Career Dr. Atay began his
The Massachusetts Attorney General’s Office has issued 104 indictments to a developer it fears raised the risk of malignant mesothelioma to thousands. The company is accused of illegally demolishing a former elementary school, spreading asbestos dust to a large neighborhood and exposing its own workers to the carcinogenic material at the same time.
Dr. Matthew A. Gubens is a thoracic oncologist at the UCSF Health Thoracic Surgery and Oncology Clinic and the Helen Diller Family Comprehensive Cancer Center. He specializes in treating patients diagnosed with non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and pleural mesothelioma. Dr. Gubens is actively involved in research seeking
Dr. Hitesh Batra is an interventional pulmonologist with a special interest in pleural diseases, including malignant pleural mesothelioma. He is Director of the University of Alabama at Birmingham (UAB) Hospital’s Interventional Pulmonology and Pleural Disease program, the state’s first and only interventional pulmonary program. Education and Career Dr. Batra earned his medical degree at the
Dr. Julie Renee Brahmer is a medical oncologist and international leader in the development of new therapies for the treatment and prevention of lung cancer and pleural mesothelioma. Her positions at the Sidney Kimmel Comprehensive Cancer Center include Co-Director of the Cancer Immunology Program and Director of Thoracic Oncology. Her particular expertise lies in drug
Dr. Heather Wakelee is a medical oncologist specializing in thoracic cancers, like lung cancer and pleural mesothelioma. She sees patients at the Thoracic Cancer Program at Stanford in Palo Alto, California. After years of developing a research program and being the physician lead for Stanford’s thoracic malignancies clinical research group, she took on the role